PSNL

Personalis (PSNL)

Personalis Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PSNL

<< 이전 5 6 7 8 9 10 11 12 13 14 15 16 17 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2020/05/20	07:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2020/05/20	07:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2020/05/08	06:06	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PSNL	Personalis Inc
2020/05/08	06:06	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:PSNL	Personalis Inc
2020/05/08	05:05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PSNL	Personalis Inc
2020/05/08	05:01	Business Wire	Personalis Reports First Quarter 2020 Financial Results	NASDAQ:PSNL	Personalis Inc
2020/05/06	03:00	Business Wire	Personalis, Inc. Appoints Industry Veteran Stephen Moore as General Counsel	NASDAQ:PSNL	Personalis Inc
2020/04/30	05:05	Business Wire	Personalis to Participate at Upcoming Investor Conferences	NASDAQ:PSNL	Personalis Inc
2020/04/30	01:00	Business Wire	Personalis Announces Renewed Clinical Laboratory Accreditation from College of American Pathologists	NASDAQ:PSNL	Personalis Inc
2020/04/24	05:05	Business Wire	Personalis to Announce First Quarter 2020 Financial Results on May 7, 2020	NASDAQ:PSNL	Personalis Inc
2020/04/22	16:45	Business Wire	Indivumed, partenaire Personalis pour améliorer les capacités de séquençage du génome	NASDAQ:PSNL	Personalis Inc
2020/04/22	09:20	Business Wire	Indivumed, Personalis Partner plant den Ausbau seiner Kapazitäten zur Genomsequenzierung	NASDAQ:PSNL	Personalis Inc
2020/04/22	06:24	Business Wire	Indivumed e Personalis collaborano per accrescere le capacità di sequenziamento genomico	NASDAQ:PSNL	Personalis Inc
2020/04/22	00:31	Business Wire	Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities	NASDAQ:PSNL	Personalis Inc
2020/04/21	16:00	PR Newswire (US)	Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities	NASDAQ:PSNL	Personalis Inc
2020/04/15	00:45	Business Wire	Personalis, Inc. Expands Genomics Portfolio Across Disease Areas With Launch of Pharma Research Solutions for Use in Early Dr...	NASDAQ:PSNL	Personalis Inc
2020/04/04	06:12	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:PSNL	Personalis Inc
2020/04/04	06:07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:PSNL	Personalis Inc
2020/04/01	05:05	Business Wire	Personalis to Participate at the 19th Annual Needham Virtual Healthcare Conference	NASDAQ:PSNL	Personalis Inc
2020/03/26	06:26	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:PSNL	Personalis Inc
2020/03/26	05:16	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PSNL	Personalis Inc
2020/03/26	05:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PSNL	Personalis Inc
2020/03/26	05:01	Business Wire	Personalis Reports Fourth Quarter and Full Year 2019 Financial Results	NASDAQ:PSNL	Personalis Inc
2020/03/12	06:37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2020/03/12	06:35	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:PSNL	Personalis Inc
2020/03/12	05:05	Business Wire	Personalis to Announce Fourth Quarter and Full Year 2019 Financial Results on March 25, 2020	NASDAQ:PSNL	Personalis Inc
2020/03/05	08:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2020/02/26	22:00	Business Wire	Personalis, Inc. to Present at Immuno-Oncology 360˚ Conference	NASDAQ:PSNL	Personalis Inc
2020/02/19	12:56	Business Wire	Personalis, Inc. fera une présentation à la conférence Biomarkers Series UK 2020	NASDAQ:PSNL	Personalis Inc
2020/02/19	11:30	Business Wire	Personalis, Inc. präsentiert auf der Konferenz Biomarkers Series UK 2020	NASDAQ:PSNL	Personalis Inc